# Raymonde Busch

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/raymonde-busch/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,758 |
| Field | Chronic Lymphocytic Leukemia Research |
| h-index | 65 |
| i10-index | 152 |
| OpenAlex ID | https://openalex.org/A5111685630 |
| Works | 209 |

## Researcher papers

- [<i>TP53</i> Mutation and Survival in Chronic Lymphocytic Leukemia](https://scholariq.org/papers/i-tp53-i-mutation-and-survival-in-chronic-lymphocytic-leukemia/)
- [Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial](https://scholariq.org/papers/gene-mutations-and-treatment-outcome-in-chronic-lymphocytic-leukemia-results/)
- [Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group](https://scholariq.org/papers/bendamustine-in-combination-with-rituximab-for-previously-untreated-patients/)
- [Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group](https://scholariq.org/papers/bendamustine-combined-with-rituximab-in-patients-with-relapsed-and-or-refractory/)
- [Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial](https://scholariq.org/papers/allogeneic-stem-cell-transplantation-provides-durable-disease-control-in-poor/)
- [Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial](https://scholariq.org/papers/detailed-analysis-of-p53-pathway-defects-in-fludarabine-refractory-chronic/)

## Researcher topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.